729 related articles for article (PubMed ID: 16027260)
21. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
[TBL] [Abstract][Full Text] [Related]
22. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
23. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
[TBL] [Abstract][Full Text] [Related]
24. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
25. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
26. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
28. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
29. Troponin I and NT-proBNP (N-terminal pro-brain natriuretic peptide) do not predict 6-month mortality in frail older patients undergoing orthopedic surgery.
Chong CP; van Gaal WJ; Ryan JE; Burrell LM; Savige J; Lim WK
J Am Med Dir Assoc; 2010 Jul; 11(6):415-20. PubMed ID: 20627182
[TBL] [Abstract][Full Text] [Related]
30. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
[TBL] [Abstract][Full Text] [Related]
32. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
33. Predictors of increased cumulative serum levels of the N-terminal prohormone of brain natriuretic peptide 4 days after acute spontaneous subarachnoid hemorrhage.
Nyberg C; Karlsson T; Ronne-Engström E
J Neurosurg; 2014 Mar; 120(3):599-604. PubMed ID: 24093631
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis.
Li J; Ning B; Wang Y; Li B; Qian J; Ren H; Zhang J; Hu X
Medicine (Baltimore); 2019 Mar; 98(13):e15070. PubMed ID: 30921240
[TBL] [Abstract][Full Text] [Related]
35. Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese population.
Zhang XH; Dong Y; Chen YD; Zhou P; Wang JD; Wen FQ
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):517-21. PubMed ID: 23467952
[TBL] [Abstract][Full Text] [Related]
36. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
[TBL] [Abstract][Full Text] [Related]
37. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study.
Költő G; Vuolteenaho O; Szokodi I; Faludi R; Tornyos A; Ruskoaho H; Minier T; Czirják L; Komócsi A
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-75-81. PubMed ID: 25372791
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
Karakas M; Jaensch A; Breitling LP; Brenner H; Koenig W; Rothenbacher D
Clin Chem; 2014 Nov; 60(11):1441-9. PubMed ID: 25139456
[TBL] [Abstract][Full Text] [Related]
40. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
